Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Serina Therapeutics, Inc.

1.95
-0.0500-2.50%
Volume:46.77K
Turnover:93.36K
Market Cap:49.53M
PE:-1.01
High:2.06
Open:1.96
Low:1.95
Close:2.00
52wk High:5.83
52wk Low:1.22
Shares:25.40M
Float Shares:11.48M
Volume Ratio:0.20
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9304
EPS(LYR):-1.9100
ROE:-207.94%
ROA:-92.30%
PB:2.64
PE(LYR):-1.02

Loading ...

OverviewCompanyNewsFilings

Serina Therapeutics Q1 FY26 net loss widens to $6.9 million from Q1 FY25

Reuters
·
May 15

Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease

GlobeNewswire
·
May 04

SER Industries Gets BSE's Approval for Name Change

MT Newswires Live
·
Apr 22

Serina Therapeutics names Srini Tenjarla chief technology officer

Reuters
·
Apr 22

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

GlobeNewswire
·
Apr 20

Serina Therapeutics presents POZ-based lipid nanoparticle data at LNP formulation summit

Reuters
·
Apr 07

BRIEF-Serina Therapeutics Announces NYSE American Acceptance Of Continued Listing Compliance Plan

Reuters
·
Apr 03

NYSE American accepts Serina plan to regain listing compliance by July 2027

Reuters
·
Apr 03

Serina Therapeutics Announces Nyse American Acceptance of Continued Listing Compliance Plan

THOMSON REUTERS
·
Apr 03

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 13, 2026 Post-Mkt
Financial Report Announcement
May 14, 2026 Post-Mkt
Financial Report Announcement
Mar 25, 2026 Post-Mkt
Financial Report Announcement
Nov 13, 2025 Pre-MKt
Financial Report Announcement
Aug 11, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-1.01
Current
-9.10
Sector Average
63.38%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-1.01
Maximum
29.14
+1 STD
9.63
Minimum
-65.07
-1 STD
-27.83
Average
-9.10

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.